0 0
Advertisements
Read Time:8 Second

FDA leadership didn’t ‘receive direct copies of the complaint due to an isolated failure in FDA’s mail room, likely due to COVID-19 staffing issues’

About Post Author

Happy
0 0 %
Sad
0 0 %
Excited
0 0 %
Sleepy
0 0 %
Angry
0 0 %
Surprise
0 0 %